Published in Biochim Biophys Acta on August 16, 2012
Transforming growth factor-β signalling controls human breast cancer metastasis in a zebrafish xenograft model. Breast Cancer Res (2013) 1.02
The roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progression. Am J Pathol (2014) 0.97
Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance. J Biol Chem (2013) 0.95
Association of TGFβ signaling with the maintenance of a quiescent stem cell niche in human oral mucosa. Histochem Cell Biol (2016) 0.89
Loss of WISP2/CCN5 in estrogen-dependent MCF7 human breast cancer cells promotes a stem-like cell phenotype. PLoS One (2014) 0.87
CXCR7 mediates TGFβ1-promoted EMT and tumor-initiating features in lung cancer. Oncogene (2015) 0.86
Ovary and fimbrial stem cells: biology, niche and cancer origins. Nat Rev Mol Cell Biol (2015) 0.86
NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment. Stem Cells Int (2016) 0.83
Molecular Mechanism of Activation of Transforming Growth Factor Beta/Smads Signaling Pathway in Ets Related Gene-Positive Prostate Cancers. J Pharm Sci Pharmacol (2014) 0.78
Neuroprotective effects of SMADs in a rat model of cerebral ischemia/reperfusion. Neural Regen Res (2015) 0.78
Mesodermal ALK5 controls lung myofibroblast versus lipofibroblast cell fate. BMC Biol (2016) 0.77
Dab2 attenuates brain injury in APP/PS1 mice via targeting transforming growth factor-beta/SMAD signaling. Neural Regen Res (2014) 0.77
A Thymic Epithelial Stem Cell Pool Persists throughout Ontogeny and Is Modulated by TGF-β. Cell Rep (2016) 0.76
Transforming growth factor β in cancer: Janus, the two-faced god. J Natl Cancer Inst (2014) 0.76
Reversal of tubo-ovarian atypical epithelial patterns after cessation of ovarian stimulation by letrozole. Int J Exp Pathol (2016) 0.75
Genome-wide microarray expression and genomic alterations by array-CGH analysis in neuroblastoma stem-like cells. PLoS One (2014) 0.75
Regulation of hepcidin expression by inflammation-induced activin B. Sci Rep (2016) 0.75
Ets Related Gene and Smad3 Proteins Collaborate to Activate Transforming Growth Factor-Beta Mediated Signaling Pathway in ETS Related Gene-Positive Prostate Cancer Cells. J Pharm Sci Pharmacol (2014) 0.75
An Adult Mouse Thyroid Side Population Cell Line that Exhibits Enriched Epithelial-Mesenchymal Transition. Thyroid (2017) 0.75
Concerted loss of TGFβ-mediated proliferation control and E-cadherin disrupts epithelial homeostasis and causes oral squamous cell carcinoma. Carcinogenesis (2014) 0.75
Smad7 enables STAT3 activation and promotes pluripotency independent of TGF-β signaling. Proc Natl Acad Sci U S A (2017) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08
Epithelial-mesenchymal transitions in development and disease. Cell (2009) 39.17
Identification of human brain tumour initiating cells. Nature (2004) 38.87
The basics of epithelial-mesenchymal transition. J Clin Invest (2009) 32.82
Generation of germline-competent induced pluripotent stem cells. Nature (2007) 32.77
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 32.63
Establishment in culture of pluripotential cells from mouse embryos. Nature (1981) 30.49
Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature (2007) 29.32
Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell (2003) 25.94
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature (2006) 24.52
Identification and expansion of human colon-cancer-initiating cells. Nature (2006) 24.44
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell (2007) 22.89
Bone marrow cells regenerate infarcted myocardium. Nature (2001) 21.24
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev (2003) 20.77
Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature (2003) 20.48
Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science (1992) 19.30
Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A (1981) 18.96
Direct conversion of fibroblasts to functional neurons by defined factors. Nature (2010) 18.76
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer (2009) 18.53
Identification of pancreatic cancer stem cells. Cancer Res (2007) 18.36
Generation of a functional mammary gland from a single stem cell. Nature (2006) 18.30
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer (2008) 18.08
In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature (2008) 16.21
Purification and unique properties of mammary epithelial stem cells. Nature (2006) 15.98
Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell (1999) 15.87
TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature (1997) 15.75
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell (2010) 15.58
Defining the epithelial stem cell niche in skin. Science (2003) 14.93
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell (2007) 14.87
Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell (2008) 14.80
Epigenetic memory in induced pluripotent stem cells. Nature (2010) 14.31
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature (2011) 13.94
New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature (2007) 13.54
BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell (2003) 13.47
Smad transcription factors. Genes Dev (2005) 13.43
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol (2009) 13.16
Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell (1990) 12.13
Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature (2007) 11.72
Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol (2005) 11.18
Cellular and molecular regulation of muscle regeneration. Physiol Rev (2004) 10.72
Muscle regeneration by bone marrow-derived myogenic progenitors. Science (1998) 10.66
Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet (2008) 10.22
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene (2010) 9.66
Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol (2005) 9.58
Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol (2010) 9.24
Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One (2008) 8.97
Making sense of latent TGFbeta activation. J Cell Sci (2003) 8.90
Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med (2004) 8.89
Transcriptional control by the TGF-beta/Smad signaling system. EMBO J (2000) 8.49
Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell (2007) 8.05
Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation (2002) 7.97
Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol (2009) 7.95
A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell (2010) 7.94
TGF-beta-induced epithelial to mesenchymal transition. Cell Res (2009) 7.88
A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res (2005) 7.86
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature (2006) 7.69
Stepwise reprogramming of B cells into macrophages. Cell (2004) 7.68
Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells (2007) 7.57
Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell (2010) 7.51
BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet (2004) 7.37
Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol (2009) 7.29
Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci U S A (1989) 7.19
Naive and primed pluripotent states. Cell Stem Cell (2009) 7.15
Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science (1998) 7.08
Cells of origin in cancer. Nature (2011) 6.85
New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature (2008) 6.82
Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell (2011) 6.71
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell (2010) 6.47
Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods (2005) 6.37
Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet (2001) 6.36
Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res (2004) 6.34
Myogenic satellite cells: physiology to molecular biology. J Appl Physiol (1985) (2001) 6.27
BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol (2002) 6.20
Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell (2006) 6.19
Non-Smad TGF-beta signals. J Cell Sci (2005) 6.06
For the long run: maintaining germinal niches in the adult brain. Neuron (2004) 6.01
TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol (1994) 6.00
Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med (2006) 5.92
Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell (2001) 5.84
TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev (1996) 5.71
TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development (2005) 5.66
Non-Smad pathways in TGF-beta signaling. Cell Res (2009) 5.54
Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol (2007) 5.50
Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development (2009) 5.49
Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states. Cell Stem Cell (2008) 5.47
A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature (2011) 5.45
Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat Med (2007) 5.25
Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell (2007) 5.14
Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell (2010) 5.13
EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells. Neuron (2002) 5.06
Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci U S A (2010) 5.00
Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem (2000) 5.00
Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex. Nature (2009) 4.98
Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol (2005) 11.18
TGF-beta-induced epithelial to mesenchymal transition. Cell Res (2009) 7.88
Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol (2011) 4.06
Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol (2007) 3.47
TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol (2013) 2.80
TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J (2007) 2.57
Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J (2005) 2.35
New regulatory mechanisms of TGF-beta receptor function. Trends Cell Biol (2009) 2.34
Crystal structure of IRF-3 in complex with CBP. Structure (2005) 2.18
Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. J Biol Chem (2003) 2.00
Transforming growth factor-beta signaling in stem cells and cancer. Science (2005) 1.95
Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. Mol Cell (2010) 1.85
TGF-beta regulates the mechanical properties and composition of bone matrix. Proc Natl Acad Sci U S A (2005) 1.83
Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation. Nat Struct Biol (2003) 1.80
TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch. EMBO J (2008) 1.74
TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. J Cell Sci (2012) 1.74
Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone. PLoS One (2008) 1.60
Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes. J Cell Biol (2002) 1.58
Ki26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line. Cancer Sci (2007) 1.45
TGF-beta-activated Smad3 represses MEF2-dependent transcription in myogenic differentiation. EMBO J (2004) 1.42
Characterization of growth factor-induced serine phosphorylation of tumor necrosis factor-alpha converting enzyme and of an alternatively translated polypeptide. J Biol Chem (2003) 1.40
Essential role of TGF-beta signaling in glucose-induced cell hypertrophy. Dev Cell (2009) 1.40
Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs. Curr Opin Cell Biol (2013) 1.39
The type I TGF-beta receptor is covalently modified and regulated by sumoylation. Nat Cell Biol (2008) 1.37
TGFbeta family signaling: novel insights in development and disease. Development (2009) 1.35
Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling. J Biol Chem (2003) 1.26
Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors. J Biol Chem (2002) 1.23
Post-translational regulation of TGF-β receptor and Smad signaling. FEBS Lett (2012) 1.21
TACE-mediated ectodomain shedding of the type I TGF-beta receptor downregulates TGF-beta signaling. Mol Cell (2009) 1.17
Arginine Methylation Initiates BMP-Induced Smad Signaling. Mol Cell (2013) 1.14
Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-β-induced epithelial-mesenchymal transition. Cells Tissues Organs (2010) 1.11
TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association. Sci Signal (2012) 1.11
Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1. J Biol Chem (2005) 1.11
Characterization of a human rhomboid homolog, p100hRho/RHBDF1, which interacts with TGF-alpha family ligands. Dev Dyn (2005) 1.09
Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation. J Biol Chem (2010) 1.09
Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-beta signaling. Proc Natl Acad Sci U S A (2011) 1.07
Medicine: interfering with bone remodelling. Nature (2002) 1.06
Autocrine TGF-β protects breast cancer cells from apoptosis through reduction of BH3-only protein, Bim. J Biochem (2010) 1.03
Cornichon regulates transport and secretion of TGFalpha-related proteins in metazoan cells. J Cell Sci (2007) 0.95
Tissue-specific calibration of extracellular matrix material properties by transforming growth factor-β and Runx2 in bone is required for hearing. EMBO Rep (2010) 0.95
Smad2 is essential for maintenance of the human and mouse primed pluripotent stem cell state. J Biol Chem (2013) 0.94
Identification of the GATA factor TRPS1 as a repressor of the osteocalcin promoter. J Biol Chem (2009) 0.94
Transforming growth factor beta/Smad3 signaling regulates IRF-7 function and transcriptional activation of the beta interferon promoter. Mol Cell Biol (2004) 0.93
Prostate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals. J Biol Chem (2012) 0.93
Association of tetraspanin CD9 with transmembrane TGF{alpha} confers alterations in cell-surface presentation of TGF{alpha} and cytoskeletal organization. J Cell Sci (2008) 0.91
Oncogene and tumour suppressor: the two faces of SnoN. EMBO J (2009) 0.82
JNK regulates expression and autocrine signaling of TGF-beta1. Mol Cell (2004) 0.81
Differential gene expression between juvenile and adult dura mater: a window into what genes play a role in the regeneration of membranous bone. Plast Reconstr Surg (2006) 0.80
Pillars Article: production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986. 163: 1037-1050. J Immunol (2014) 0.79